Asosiy kontentga oʻtish
Sharh maqola

Role of exosomal microRNAs in lung cancer biology and clinical applications

Chengping HuDepartment of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, ChinaSilke MeinersComprehensive Pneumology Center and Institute for Lung Biology and Disease University Hospital Ludwig‐Maximilians University of Munich Munich GermanyChristina LukasHelmholtz Center Munich Munich GermanyGeorgios T. StathopoulosLaboratory for Molecular Respiratory Carcinogenesis Department of Physiology Faculty of Medicine Biomedical Sciences Research Center University of Patras Rio GreeceJie ChenDepartment of Respiratory Medicine Xiangya Hospital Central South University Changsha China
2020en
ABI

Annotatsiya

Exosomes, small extracellular vesicles ranging from 30 to 150 nm, are secreted by various cell types, including tumour cells. Recently, microRNAs (miRNAs) were identified to be encapsulated and hence protected from degradation within exosomes. These exosomal miRNAs can be horizontally transferred to target cells, in which they subsequently modulate biological processes. Increasing evidence indicates that exosomal miRNAs play a critical role in modifying the microenvironment of lung cancers, possibly facilitating progression, invasion, angiogenesis, metastasis and drug resistance. In this review, we summarize the novel findings on exosomal miRNA functions during lung cancer initiation and progression. In addition, we highlight their potential role and challenges as biomarkers in lung cancer diagnosis, prognosis and drug resistance and as therapeutic agents.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba